Valuation Zai Lab Limited BOERSE MUENCHEN

Stocks

Real-time BOERSE MUENCHEN Other stock markets 16:43:26 30/06/2026 BST			5-day change	1st Jan Change
16.30 ^EUR	+2.52%		-2.45%	+6.71%

06-16	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT
06-10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	2,068	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	5.43%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,625	1,681	1,854
Change	-	-58.33%	-2.13%	10.47%	-33.34%	16.38%	3.44%	10.27%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-8.31x	-9.87x	-13.7x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.87x	4.16x	4.12x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.5x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.61x	3.47x	2.74x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.62x	2.82x	2.45x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.69x	-10.5x	-27.8x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-6.28x	-9.68x	-21.6x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-9.24x	-14.5x	-26.4x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-10.8%	-6.89%	-3.79%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.215	-1.865	-1.347
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	448.7	595.6	755.9
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-243	-159.9	-66.57
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-258.7	-173.7	-85.83
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-240.9	-156.5	-125.8
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-443.1	-387.2	-214.4
Reference price ²	62.85	30.70	27.33	26.19	17.64	18.41	18.41	18.41
Nbr of stocks (in thousands)	96,409	95,972	98,349	108,937	111,219	112,355	-	-
Announcement Date	01/03/22	01/03/23	27/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	16.36x	3.55x	9.58x	0.62%	64.28B
UCB	28.32x	5.77x	16.88x	0.56%	57.29B
SAMSUNG BIOLOGICS CO.,LTD.	35.89x	12.16x	23.03x	-.--%	43.45B
CSL LIMITED	-56.58x	3.05x	9x	3.59%	38.02B
BIOGEN INC.	34.98x	3.72x	11.41x	-.--%	31.98B
MODERNA, INC.	-8.06x	11.55x	-7.04x	-.--%	27.66B
INCYTE CORPORATION	16.64x	3.17x	9.59x	-.--%	22.91B
INNOVENT BIOLOGICS, INC.	50.41x	5.55x	38.45x	-.--%	17.74B
SWEDISH ORPHAN BIOVITRUM AB	25.58x	5.32x	14.26x	-.--%	16.45B
Average	15.95x	5.98x	13.91x	0.53%	35.53B
Weighted average by Cap.	14.62x	5.94x	13.24x	0.65%